IntroductionIn the last decades, the possible effects of unsubstituted deoxyhexoses on tumor cells and their use in cancer treatment have been discussed. Above all, 2-deoxy-D-glucose (2-DG) and L-fucose have been studied in numerous works both in vitro and in vivo. 2-Deoxyglucose is a synthetic glucose analogue that inhibits phospho-hexose isomerase in the initial stage of glycolysis (29,33) and induces glucoseregulated stress affecting tumor cells in particular (9, 42). The inhibitory effect of 2-DG on tumor growth has been reported in both in vitro (43) and in vivo (5, 10) studies. Glycolysis inhibition and resulting energy depletion trigger apoptotic cell death. The mechanisms include inhibition of phosphatidylinositol 3-kinase/Akt signaling (35), increased production of reactive oxygen species, interference with MAPK pathways and stabilization of p53 (19). Corresponding to this, 2-DG was found to induce cell death by the activation of apoptosis (1). Regardless of the mechanism which triggers apoptosis by either intrinsic (mitochondrial) or extrinsic (receptor) pathways, the apoptotic cells can be recognized by specific morphological changes: membrane blebbing, condensation, fragmentation of nuclear DNA, cleavage of nuclear proteins (e.g. lamin B) and formation of apoptotic bodies.L-fucose (6-deoxy-L-galactose) is the only endogenous deoxyhexose known in humans. Although a research group reported the effect of intravenously administered L-fucose on the size of a rat solid mammary adenocarcinoma in vivo (25, 41) as well as the efficacy of this deoxysugar in vitro (21,24,28,40), no significant cytostatic potency of single L-fucose in vitro or L-fucose monotherapy has been confirmed in the recent literature. However, it has been noted that L-fucose enhances the cytolytic activity of immune system effector cells and the production of cytokines like interleukin 2 and tumor necrosis factor α (30). It is well documented that altered fucosylation plays an important role in the pathogenesis of malignant tumors (3,11,12). A potential antimetastatic effect of L-fucose and L-fucose containing oligosaccharides was reported as well (26).In nature, there is another deoxyhexose -L-rhamnose (6-deoxy-L-mannose) -similar to deoxyglucose. It is synthesized largely in plants and bacteria but not in animal cells (7). Since L-rhamnose can serve as substrate for L-fucose kinase (8), which catalyzes the first step in the salvage pathway for GDP-fucose biosynthesis (3), a hypothesis can be formulated that L-rhamnose could influence the fucosylation and thereby the behavior of tumor cells. The fact that L-rhamnose can be converted into glycosides in mammalian cells has been indeed evidenced by sporadic discoveries of rhamnosides in mammals (14, 34). Moreover, L-rhamnose, which penetrates by non-mediated diffusion into the cells (4), may be partially metabolized or join some human metabolic pathways (6,13 Summary: The effect of unsubstituted deoxyhexoses, 2-deoxy-D-glucose (2-DG) and L-fucose, on tumor cells has been reported in several...